Discontinue treatment when symptoms of shock eg, chest anxiety, dyspnea, decreased BP, cyanosis, urticaria & discomfort occur; jaundice appears. Phlebitis & angialgia following IV administration. Patients whose parents or siblings are predisposed to develop allergic reactions eg, bronchial asthma, rash & urticaria. Periodically perform liver & kidney function tests as well as hematological tests in patients on long term therapy. Patients on restricted Na diet. Liver disorders. Avoid use during pregnancy.